RS693668 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| PCSK9 protein levels | A | OR: 0.14 | 1E-134 | PubMed |
| Serum levels of protein PCSK9 | G | OR: 0.19 | 6E-21 | PubMed |
| Medication use (HMG CoA reductase inhibitors) | G | β: 0.049 | 7E-17 | PubMed |
| Polyunsaturated fatty acid levels | G | — | 3E-16 | PubMed |
| Free cholesterol to total lipids ratio in very small VLDL | G | β: 0.034 | 2E-15 | PubMed |
| Triglycerides to total lipids ratio in small VLDL | G | β: 0.032 | 8E-15 | PubMed |
| Cholesterol to total lipids ratio in small VLDL | G | β: 0.032 | 1E-14 | PubMed |
| LDL x anxiety interaction (2df test) | A | OR: 0.7 | 2E-14 | PubMed |
| Proprotein convertase subtilisin/kexin type 9 levels | A | OR: 0.1 | 4E-14 | PubMed |
| Phospholipids to total lipids ratio in large HDL | G | β: 0.032 | 4E-14 | PubMed |
| Low density lipoprotein cholesterol levels | — | β: 0.062 | 1E-13 | PubMed |
| Phospholipids to total lipids ratio in medium VLDL | G | β: 0.03 | 2E-13 | PubMed |
| Free cholesterol to total lipids ratio in medium VLDL | G | β: 0.03 | 3E-13 | PubMed |
| Free cholesterol to total lipids ratio in small HDL | G | β: 0.029 | 1E-12 | PubMed |
| Cholesteryl esters to total lipids ratio in small VLDL | G | β: 0.03 | 2E-12 | PubMed |
| Phospholipids to total lipids ratio in small HDL | G | β: 0.029 | 3E-12 | PubMed |
| Triglycerides to total lipids ratio in medium VLDL | G | β: 0.028 | 6E-12 | PubMed |
| Omega-6 fatty acid levels | G | — | 2E-11 | PubMed |
| Linoleic acid levels | G | — | 2E-11 | PubMed |
| Cholesterol to total lipids in small VLDL percentage (UKB data field 23600) | G | β: 0.032 | 3E-11 | PubMed |